Rapid effects of aldosterone in primary cultures of cardiomyocytes – do they suggest the existence of a membrane-bound receptor?

References

• Rossier MF, Python M, Maturana AD. Contribution of mineralocorticoid and glucocorticoid receptors to the chronotropic and hypertrophic actions of aldosterone in neonatal rat ventricular myocytes. Endocrinology 2010;151:2777–87
   PubMed Web of Science ®Google Scholar
• Hermidorff MM, de Assis LVM, Isoldi MC. Antagonists of the mineralocorticoid receptor or a new pharmacological class? J Cell Sci Ther 2015;1-2:6
   Google Scholar
• Nagata K, Somura F, Obata K, et al. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats. Hypertension 2002;40:168–74
   PubMed Web of Science ®Google Scholar
• Tan Y, Li S, Pitt BR, Huang L. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum Gene Ther 1999;10:2153–61
   PubMed Web of Science ®Google Scholar
• Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309–21
   PubMed Web of Science ®Google Scholar
• Young MJ. Targeting the mineralocorticoid receptor in cardiovascular disease. Expert Opin Ther Targets 2013;17:321–31
   PubMed Web of Science ®Google Scholar
• Yang J, Chang CY, Safi R, et al. Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display. Mol Endocrinol 2011;25:32–43
   PubMed Web of Science ®Google Scholar
• Haseroth K, Gerdes D, Berger S, et al. Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice. Biochem Biophys Res Commun 1999;266:257–61
   PubMed Web of Science ®Google Scholar
• Grossmann C, Gekle M. New aspects of rapid aldosterone signaling. Mol Cell Endocrinol 2009;308:53–62
   PubMed Web of Science ®Google Scholar
• Feldman RD, Gros R. Unraveling the mechanisms underlying the rapid vascular effects of steroids: sorting out the receptors and the pathways. Br J Pharmacol 2011;163:1163–9
   PubMed Web of Science ®Google Scholar
• Hermidorff MM, Faria Gde O, Amâncio Gde C, et al. Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways? Biochem Cell Biol 2015;93:83–93
   PubMed Web of Science ®Google Scholar
• Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 2003;65:45–79
   PubMed Web of Science ®Google Scholar
• Locatelli J, de Assis LV, Isoldi MC. Calcium handling proteins: structure, function, and modulation by exercise. Heart Fail Rev 2014;19:207–25
   PubMed Web of Science ®Google Scholar
• Locatelli J, de Assis LVM, Araújo CM, et al. Swimming training promotes cardiac remodeling and alters the expression of mRNA and protein levels involved in calcium handling in hypertensive rats. Life Sci 2014;117:67–74
   PubMed Web of Science ®Google Scholar
• Nishida H, Sato T, Ogura T, Nakaya H. New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: mitochondrial ion channels and cardioprotection. J Pharmacol Sci 2009;109:341–7
   PubMed Web of Science ®Google Scholar
• Gómez AM, Ruiz-Hurtado G, Benitah JP, Domínguez-Rodríguez A. Ca(2+) fluxes involvement in gene expression during cardiac hypertrophy. Curr Vasc Pharmacol 2013;11:497–506
   PubMed Web of Science ®Google Scholar
• Garland SL. Are GPCRs still a source of new targets? J Biomol Screen 2013;18:947–66
   PubMed Web of Science ®Google Scholar
• Falkenstein E, Christ M, Feuring M, Wehling M. Specific nongenomic actions of aldosterone. Kidney Int 2000;57:1390–4
   PubMed Web of Science ®Google Scholar
• Uhrenholt TR, Schjerning J, Hansen PB, et al. Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone. Circ Res 2003;93:1258–66
   PubMed Web of Science ®Google Scholar
• Grossmann C, Benesic A, Krug AW, et al. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions. Mol Endocrinol 2005;19:1697–710
   PubMed Web of Science ®Google Scholar
• Good DW, George T, Watts BA 3rd. Aldosterone inhibits HCO absorption via a nongenomic pathway in medullary thick ascending limb. Am J Physiol Renal Physiol 2002;283:F699–706
   Google Scholar
• Falkenstein E, Tillmann HC, Christ M, et al. Multiple actions of steroid hormones – a focus on rapid, nongenomic effects. Pharmacol Rev 2000;52:513–56
   PubMed Web of Science ®Google Scholar
• Gros R, Ding Q, Liu B, et al. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am J Physiol Cell Physiol 2013;304:C532–40
   PubMed Web of Science ®Google Scholar
• Gros R, Ding Q, Sklar LA, et al. GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone. Hypertension 2011;57:442–51
   PubMed Web of Science ®Google Scholar
• Wong W, Scott JD. AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 2004;5:959–70
   PubMed Web of Science ®Google Scholar
• Beene DL, Scott JD. A-kinase anchoring proteins take shape. Curr Opin Cell Biol 2007;19:192–8
   PubMed Web of Science ®Google Scholar
• Molkentin JD, Dorn GW 2nd. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 2001;63:391–426
   PubMed Web of Science ®Google Scholar
• Marx SO, Reiken S, Hisamatsu Y, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000;101:365–76
   PubMed Web of Science ®Google Scholar
• Rababa'h A, Singh S, Suryavanshi SV, et al. Compartmentalization role of A-kinase anchoring proteins (AKAPs) in mediating protein kinase A (PKA) signaling and cardiomyocyte hypertrophy. Int J Mol Sci 2014;24:218–29
   Web of Science ®Google Scholar
• Kapiloff MS. Contributions of protein kinase A anchoring proteins to compartmentation of cAMP signaling in the heart. Mol Pharmacol 2002;62:193–9
   PubMed Web of Science ®Google Scholar
• Barreto-Chaves ML, Heimann A, Krieger JE. Stimulatory effect of dexamethasone on angiotensin-converting enzyme in neonatal rat cardiac myocytes. Braz J Med Biol Res 2000;33:661–4
   PubMed Web of Science ®Google Scholar
• Losel RM, Falkenstein E, Feuring M, et al. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev 2003;83:965–1016
   PubMed Web of Science ®Google Scholar
• Verrey F. Early aldosterone effects. Exp Nephrol 1998;6:294–301
   PubMedGoogle Scholar
• Köhler E, Bertschin S, Woodtli T, et al. Does aldosterone-induced cardiac fibrosis involve direct effects on cardiac fibroblasts? J Vasc Res 1996;33:315–26.
   PubMed Web of Science ®Google Scholar
• Verhovez A, Williams TA, Morello F, et al. Aldosterone does not modify gene expression in human endothelial cells. Horm Metab Res 2012;44:234–8
   PubMed Web of Science ®Google Scholar
• Lin YH, Chou CH, Wu XM, et al. Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans. PLoS One 2014;9:e95254
   Google Scholar
• Marino GI, Assef YA, Kotsias BA. The migratory capacity of human trophoblastic BeWo cells: effects of aldosterone and the epithelial sodium channel. J Membr Biol 2013;246:243–55
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim JH, Kim JS, et al. AMP-activated protein kinase inhibits TGF-beta-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition. Am J Physiol Renal Physiol 2013;304:F686–97
   PubMed Web of Science ®Google Scholar
• Gravez B, Tarjus A, Jimenez-Canino R, et al. The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes. PLoS One 2013;8:e73737
   PubMed Web of Science ®Google Scholar
• Mihailidou AS, Loan Le TY, Mardini M, Funder JW. Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 2009;54:1306–12
   PubMed Web of Science ®Google Scholar
• Coelho-Filho OR, Shah RV, Neilan TG, et al. Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone. J Am Heart Assoc 2014;3:e000790
   PubMed Web of Science ®Google Scholar
• Houng AK, McNamee RA, Kerner A, et al. Atrial natriuretic peptide increases inflammation, infarct size, and mortality after experimental coronary occlusion. Am J Physiol Heart Circ Physiol 2009;296:H655–61
   Google Scholar
• Franchini KG. Hipertrofia cardíaca: mecanismos moleculares. Rev Bras Hipertens 2001;8:125–42
   Google Scholar
• Dong ZL, Wang Y, Li TF, et al. p42/p44 mitogen-activated protein kinases inhibit atrial natriuretic peptide mRNA transcription in gp130-mediated hypertrophic ventricular myocytes. Asian Pac J Trop Med 2014;7:216–20
   PubMed Web of Science ®Google Scholar
• Rose M, Balakumar P, Singh M. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats. Pharmacology 2007;80:177–84
   PubMed Web of Science ®Google Scholar
• Bers DM. Cardiac excitation-contraction coupling. Nature 2002;415:198–205
   PubMed Web of Science ®Google Scholar
• Kamalov G, Ahokas RA, Zhao W, et al. Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism. Am J Physiol Heart Circ Physiol 2010;298:H385–94
   Google Scholar
• de Almeida PW, de Freitas Lima R, de Morais Gomes ER, et al. Functional cross-talk between aldosterone and angiotensin-(1-7) in ventricular myocytes. Hypertension 2013;61:425–30
   PubMed Web of Science ®Google Scholar
• Nakao S, Wakabayashi S, Nakamura TY. Stimulus-dependent regulation of nuclear Ca2+ signaling in cardiomyocytes: a role of neuronal calcium sensor-1. PLoS One 2015;10:e0125050
   Google Scholar
• Yano M, Ikeda Y, Matsuzaki M. Altered intracellular Ca2+ handling in heart failure. J Clin Invest 2005;115:556–64
   PubMed Web of Science ®Google Scholar
• Lou Q, Janardhan A, Efimov IR. Remodeling of calcium handling in human heart failure. In: Islam MS, ed. Calcium signaling. Netherlands: Springer; 2012:1145–74
   Google Scholar
• Marks AR. Calcium and the heart: a question of life and death. J Clin Invest 2003;111:597–600
   PubMed Web of Science ®Google Scholar
• Carnegie GK, Means CK, Scott JD. A-kinase anchoring proteins: from protein complexes to physiology and disease. IUBMB Life 2009;61:394–406
   PubMed Web of Science ®Google Scholar
• Pare GC, Bauman AL, McHenry M, et al. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. J Cell Sci 2005;118:5637–46
   PubMed Web of Science ®Google Scholar
• Dodge-Kafka KL, Soughayer J, Pare GC, et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 2005;437:574–8
   PubMed Web of Science ®Google Scholar
• Diviani D. Modulation of cardiac function by A-kinase anchoring proteins. Curr Opin Pharmacol 2008;8:166–73
   PubMed Web of Science ®Google Scholar
• Diviani D, Dodge-Kafka KL, Li J, Kapiloff MS. A-kinase anchoring proteins: scaffolding proteins in the heart. Am J Physiol Heart Circ Physiol 2011;301:H1742–53
   PubMedGoogle Scholar
• Michel JJ, Townley IK, Dodge-Kafka KL, et al. Spatial restriction of PDK1 activation cascades by anchoring to mAKAPalpha. Mol Cell 2005;20:661–72
   PubMed Web of Science ®Google Scholar
• Bauman AL, Michel JJ, Henson E, et al. The mAKAP signalosome and cardiac myocyte hypertrophy. IUBMB Life 2007;59:163–9
   PubMed Web of Science ®Google Scholar
• Blant A, Czubryt MP. Promotion and inhibition of cardiac hypertrophy by A-kinase anchor proteins. Can J Physiol Pharmacol 2012;90:1161–70
   PubMed Web of Science ®Google Scholar
• Huang LJ, Durick K, Weiner JA, et al. Identification of a novel protein kinase A anchoring protein that binds both type I and type II regulatory subunits. J Biol Chem 1997;272:8057–64
   PubMed Web of Science ®Google Scholar
• Li X, Matta SM, Sullivan RD, Bahouth SW. Carvedilol reverses cardiac insufficiency in AKAP5 knockout mice by normalizing the activities of calcineurin and CaMKII. Cardiovasc Res 2014;104:270–79
   PubMed Web of Science ®Google Scholar
• Huang LJ, Durick K, Weiner JA, et al. D-AKAP2, a novel protein kinase A anchoring protein with a putative RGS domain. Proc Natl Acad Sci USA 1997;94:11184–9
   PubMed Web of Science ®Google Scholar
• Kapiloff MS, Schillace RV, Westphal AM, Scott JD. mAKAP: an A-kinase anchoring protein targeted to the nuclear membrane of differentiated myocytes. J Cell Sci 1999;112:2725–36
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Yoshida K, Nakano S, et al. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts. Hypertension 2006;47:671–9
   PubMed Web of Science ®Google Scholar
• Zhao Z, Wang W, Geng J, et al. Protein kinase C epsilon-dependent extracellular signal-regulated kinase 5 phosphorylation and nuclear translocation involved in cardiomyocyte hypertrophy with angiotensin II stimulation. J Cell Biochem 2010;109:653–62
   PubMed Web of Science ®Google Scholar
• Bowling N, Walsh RA, Song G, et al. Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation 1999;99:384–91
   PubMed Web of Science ®Google Scholar
• Sabri A, Hughie HH, Lucchesi PA. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid Redox Signal 2003;5:731–40
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhao M, Liu X, et al. Urotensin II receptor in the rat airway smooth muscle and its effect on the rat airway smooth muscle cells proliferation. Chin Med Sci J 2001;16:231–5
   PubMedGoogle Scholar
• Takeishi Y, Ping P, Bolli R, et al. Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy. Circ Res 2000;86:1218–23
   PubMed Web of Science ®Google Scholar
• Robert V, Heymes C, Silvestre JS, et al. Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis. Hypertension 1999;33:981–6
   PubMed Web of Science ®Google Scholar
• Ha CH, Kim JY, Zhao J, et al. PKA phosphorylates histone deacetylase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyocyte hypertrophy. Proc Natl Acad Sci 2010;107:15467–72
   PubMed Web of Science ®Google Scholar
• Abi-Gerges A, Richter W, Lefebvre F, et al. Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on β-adrenergic cAMP signals. Circ Res 2009;105:784–92
   PubMed Web of Science ®Google Scholar
• Zaccolo M. cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies. Br J Pharmacol 2009;158:50–60
   PubMed Web of Science ®Google Scholar
• Cazorla O, Lucas A, Poirier F, et al. The cAMP binding protein Epac regulates cardiac myofilament function. Proc Natl Acad Sci USA 2009;106:14144–9
   PubMed Web of Science ®Google Scholar
• Markou T, Hadzopoulou-Cladaras M, Lazou A. Phenylephrine induces activation of CREB in adult rat cardiac myocytes through MSK1 and PKA signaling pathways. J Mol Cell Cardiol 2004;37:1001–11
   PubMed Web of Science ®Google Scholar
• Somvanshi RK, Qiu X, Kumar U. Isoproterenol induced hypertrophy and associated signaling pathways are modulated by somatostatin in H9c2 cells. Int J Cardiol 2013;167:1012–22
   PubMed Web of Science ®Google Scholar
• Núñez L, Valero RA, Senovilla L, et al. Cell proliferation depends on mitochondrial Ca2+ uptake: inhibition by salicylate. J Physiol 2006;571:57–73
   PubMed Web of Science ®Google Scholar
• Mihailidou AS, Funder JW. Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system. Steroids 2005;70:347–51
   PubMed Web of Science ®Google Scholar
• Euler G. Good and bad sides of TGFβ-signaling in myocardial infarction. Front Physiol 2015;6:66
   PubMed Web of Science ®Google Scholar
• Aoyagi T, Matsui T. Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure. Curr Pharm Des 2011;17:1818–24
   PubMed Web of Science ®Google Scholar
• Sag CM, Santos CX, Shah AM. Redox regulation of cardiac hypertrophy. J Mol Cell Cardiol 2014;73:103–11
   PubMed Web of Science ®Google Scholar
• Tanaka K, Honda M, Takabatake T. Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. J Am Coll Cardiol 2001;37:676–85
   PubMed Web of Science ®Google Scholar
• Ashton AW, Le TY, Gomez-Sanchez CE, et al. Role of non-genomic signalling pathways activated by aldosterone during cardiac reperfusion injury. Mol Endocrinol 2015;29:1144–55
   PubMed Web of Science ®Google Scholar
• De Giusti VC, Orlowski A, Ciancio MC, et al. Aldosterone stimulates the cardiac sodium/bicarbonate cotransporter via activation of the g protein-coupled receptor gpr30. J Mol Cell Cardiol 2015
   PubMed Web of Science ®Google Scholar
• Ren Y, D’Ambrosio MA, Garvin JL, et al. Aldosterone sensitizes connecting tubule glomerular feedback via the aldosterone receptor GPR30. Am J Physiol Renal Physiol 2014;307:F427–34
   Google Scholar
• Fujisaki M, Nagoshi T, Nishikawa T, et al. Rapid induction of aldosterone synthesis in cultured neonatal rat cardiomyocytes under high glucose conditions. Biomed Res Int 2013;2013:1–6
   Web of Science ®Google Scholar
• Katoh D, Hongo K, Ito K, et al. A technique for quantifying intracellular free sodium ion using a microplate reader in combination with sodium-binding benzofuran isophthalate and probenecid in cultured neonatal rat cardiomyocytes. BMC Res Notes 2013;6:556
   PubMedGoogle Scholar
• Xiao TT, Wang YY, Zhang Y, et al. Similar to spironolactone, oxymatrine is protective in aldosterone-induced cardiomyocyte injury via inhibition of calpain and apoptosis-inducing factor signaling. PLoS One 2014;9:e88856
   PubMed Web of Science ®Google Scholar
• Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol. 2006;7:589–600
   PubMed Web of Science ®Google Scholar
• Edinger RS, Bertrand CA, Rondandino C, Apodaca GA, Johnson JP, Butterworth MB. The epithelial sodium channel (ENaC) establishes a trafficking vesicle pool responsible for its regulation. PLoS One. 2012;7:e46593. Available at http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0046593
   Google Scholar
• Sheader EA, Wargent ET, Ashton N, Balment RJ. Rapid stimulation of cyclic AMP production by aldosterone in rat inner medullary collecting ducts. J Endocrinol. 2002;175:343–7. Available: http://www.ncbi.nlm.nih.gov/pubmed/12429032
   PubMed Web of Science ®Google Scholar